VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ATPCAgape ATP Corporation
$3.88$4M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

ATPC logoAgape ATP Corporation(ATPC)Earnings, Financials & Key Ratios

ATPC•NASDAQ
Price updated Jun 19, 2026
SectorConsumer DefensiveIndustryPackaged FoodsSub-IndustryNutrition and functional foods
AboutAgape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.Show more
  • Revenue$2M+15.2%
  • EBITDA-$3M-29.1%
  • Net Income-$2M+7.7%
  • EPS (Diluted)-2.85+91.0%
  • Gross Margin53.67%-6.5%
  • EBITDA Margin-198.7%-12.0%
  • Operating Margin-213.65%-9.8%
  • Net Margin-149.57%+19.9%
  • ROE-18.72%+76.1%

ATPC Key Insights

Agape ATP Corporation (ATPC) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Share count reduced 36.9% through buybacks
  • ✓Trading at only 0.1x book value

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Sales declining 15.1% over 5 years
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when ATPC posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ATPC Price & Volume

Agape ATP Corporation (ATPC) stock price & volume — 10-year historical chart

Loading chart...

ATPC Growth Metrics

Agape ATP Corporation (ATPC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-15.09%
3 Years-6.36%
TTM16.68%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM22.41%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM92.57%

Return on Capital

10 Years-31.4%
5 Years-54.29%
3 Years-57.01%
Last Year-26.42%

ATPC Recent Earnings

Agape ATP Corporation (ATPC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
Q2 2026Latest
May 15, 2026
Metric
Actual
Est
EPS
$0.33
—
Rev
$399,133
—
Q2 2026
May 13, 2026
Metric
Actual
Est
EPS
$0.38
—
Rev
$399,133
—
Q2 2026
Mar 30, 2026
Metric
Actual
Est
EPS
$10.00
—
Rev
$273,658
—
Q4 2025
Nov 13, 2025
Metric
Actual
Est
EPS
$0.01
—
Rev
$370,593
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 15, 2026
$0.33
$399,133
Q2 2026May 13, 2026
$0.38
$399,133
Q2 2026Mar 30, 2026
$10.00
$273,658
Q4 2025Nov 13, 2025
$0.01
$370,593
Based on last 12 quarters of dataView full earnings history →

ATPC Peer Comparison

Agape ATP Corporation (ATPC) competitors in Nutrition and functional foods — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
NHTC logoNHTCNatural Health Trends Corp.Direct Competitor20.31M1.82-23.73-7.42%-3.03%-4.88%0.13
CLPS logoCLPSCLPS IncorporationDirect Competitor27.8M0.99-3.8215.17%-1.27%-6.06%0.59
USNA logoUSNAUSANA Health Sciences, Inc.Product Competitor348.47M18.8832.558.28%1.16%1.84%0.02
NUS logoNUSNu Skin Enterprises, Inc.Product Competitor243.72M5.021.58-14.26%3.78%6.84%0.45
NATR logoNATRNature's Sunshine Products, Inc.Product Competitor353.81M20.1218.985.67%4.06%12.08%0.12
HLF logoHLFHerbalife Nutrition Ltd.Supply Chain1.23B11.905.410.89%4.67%
VITL logoVITLVital Farms, Inc.Supply Chain446.05M10.417.2325.26%6.1%14.47%0.15
BYFC logoBYFCBroadway Financial CorporationOften Compared92.08M9.90-3.07-3.76%-39.3%-9.05%0.58

Compare ATPC vs Peers

Agape ATP Corporation (ATPC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NHTC

Most directly comparable listed peer for ATPC.

Scale Benchmark

vs HLF

Larger-name benchmark to compare ATPC against a more recognizable public peer.

Peer Set

Compare Top 5

vs NHTC, CLPS, USNA, NUS

ATPC Income Statement

Agape ATP Corporation (ATPC) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricJun'18Jun'19Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
487K1.55M858.72K3.45M1.02M1.86M1.43M1.32M1.52M1.51M
Revenue Growth %
-217.46%-44.46%302.06%-70.55%82.56%-22.92%-7.57%15.23%16.68%
Cost of Goods Sold
441.41K1.44M766.96K775.86K297.33K666.04K494.52K563.6K706.18K689.15K
COGS % of Revenue
90.64%92.93%89.31%22.47%29.24%35.88%34.56%42.61%46.33%-
Gross Profit
45.6K▲ 0%
109.35K▲ 139.8%
91.77K▼ 16.1%
2.68M▲ 2816.9%
719.63K▼ 73.1%
1.19M▲ 65.4%
936.57K▼ 21.3%
759.15K▼ 18.9%
818.08K▲ 7.8%
819.73K▲ 0%
Gross Margin %
9.36%7.07%10.69%77.53%70.76%64.13%65.44%57.39%53.67%54.33%
Gross Profit Growth %
-139.83%-16.08%2816.95%-73.12%65.44%-21.33%-18.94%7.76%-
Operating Expenses
276.47K607.36K624.54K2.83M2.58M2.72M3.08M3.33M4.07M4.03M
OpEx % of Revenue
56.77%39.28%72.73%82.11%253.52%146.71%215.44%251.94%267.32%-
Selling, General & Admin
265.68K607.36K624.54K2.83M2.46M2.72M3.08M3.33M3.54M3.57M
SG&A % of Revenue
54.55%39.28%72.73%82.11%241.57%146.71%215.44%251.94%232.05%-
Research & Development
0000000000
R&D % of Revenue
----------
Other Operating Expenses
-14K000121.51K000537.65K464.76K
Operating Income
-366.96K▲ 0%
-514.51K▼ 40.2%
-532.77K▼ 3.5%
-158.13K▲ 70.3%
-1.86M▼ 1075.3%
-1.53M▲ 17.5%
-2.15M▼ 40.0%
-2.57M▼ 19.9%
-3.26M▼ 26.6%
-3.21M▲ 0%
Operating Margin %
-75.35%-33.28%-62.04%-4.58%-182.76%-82.59%-150%-194.55%-213.65%-212.98%
Operating Income Growth %
-386.94%-40.21%-3.55%70.32%-1075.3%17.5%-40%-19.88%-26.55%-
EBITDA
-132.88K-353.37K-677.87K5.34K-1.64M-1.32M-1.92M-2.35M-3.03M-2.99M
EBITDA Margin %
-27.28%-22.86%-78.94%0.15%-161.4%-70.85%-134.4%-177.41%-198.7%-198.06%
EBITDA Growth %
--165.94%-91.83%100.79%-30848.58%19.86%-46.23%-22.01%-29.06%-27.75%
D&A (Non-Cash Add-back)
234.09K161.14K0163.47K217.21K217.94K223.19K226.65K227.98K225.05K
EBIT
-234.09K-131.17K-677.87K-158.13K-1.86M-1.53M-2.15M-2.57M-3.26M-3.21M
Net Interest Income
000025.57K16.19K29.25K67.93K3.42K153
Interest Income
000025.57K16.19K29.25K67.93K3.42K153
Interest Expense
0000000000
Other Income/Expense
109.15K-5.13K-145.09K674.48K-529.04K-136.87K40.22K92.23K951.33K1.28M
Pretax Income
-124.94K▲ 0%
-519.64K▼ 315.9%
-677.86K▼ 30.4%
516.35K▲ 176.2%
-2.39M▼ 562.4%
-1.67M▲ 30.1%
-2.11M▼ 26.1%
-2.48M▼ 17.8%
-2.31M▲ 7.1%
-1.93M▲ 0%
Pretax Margin %
-25.65%-33.61%-78.94%14.96%-234.78%-89.96%-147.19%-187.57%-151.24%-128.13%
Income Tax
5.33K00161.58K137.07K-4.05K3.58K4.93K2.29K2.29K
Effective Tax Rate %
-4.27%0%0%31.29%-5.74%0.24%-0.17%-0.2%-0.1%-0.12%
Net Income
-130.27K▲ 0%
-519.64K▼ 298.9%
-677.86K▼ 30.4%
354.77K▲ 152.3%
-2.52M▼ 811.5%
-1.69M▲ 33.2%
-2.1M▼ 24.6%
-2.47M▼ 17.5%
-2.28M▲ 7.7%
-1.91M▲ 0%
Net Margin %
-26.75%-33.61%-78.94%10.28%-248.21%-90.86%-146.88%-186.77%-149.57%-126.48%
Net Income Growth %
-72.86%-298.88%-30.45%152.34%-811.52%33.17%-24.61%-17.53%7.72%22.41%
Net Income (Continuing)
-130.27K-519.64K-677.86K354.77K-2.52M-1.67M-2.11M-2.49M-2.31M-1.94M
Discontinued Operations
0000000000
Minority Interest
0000-33620.51K11.78K-3.79K-33.45K-46.74K
EPS (Diluted)
-0.02▲ 0%
-0.07▼ 366.7%
-0.09▼ 28.6%
0.05▲ 150.0%
-0.34▼ 844.4%
-0.96▼ 186.6%
-1.39▼ 44.3%
-31.50▼ 2174.4%
-2.85▲ 91.0%
-1.91▲ 0%
EPS Growth %
-50%-366.67%-28.57%150%-844.44%-186.57%-44.27%-2174.37%90.95%92.57%
EPS (Basic)
-0.02-0.07-0.090.05-0.34-0.96-1.39-31.50-2.85-
Diluted Shares Outstanding
7.53M7.53M7.53M7.53M7.52M1.76M1.52M1.27M801.08K1M
Basic Shares Outstanding
7.47M7.53M7.53M7.53M7.52M1.76M1.52M1.27M801.08K1M
Dividend Payout Ratio
----------

ATPC Balance Sheet

Agape ATP Corporation (ATPC) balance sheet — assets, liabilities & shareholders' equity

MetricJun'18Jun'19Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
2.71M3.79M3.54M5.68M3.91M2.03M5.19M2.78M24.29M24.65M
Cash & Short-Term Investments
1.86M2.86M2.74M3.52M2.6M1.44M4.83M2.04M140.07K24.34M
Cash Only
1.86M2.86M238.94K3.52M622.5K1.44M4.83M2.04M140.07K218.91K
Short-Term Investments
002.51M01.98M000024.13M
Accounts Receivable
489.84K435.55K523K175.99K1.29K17.9K66.99K58.51K14.69K7.11K
Days Sales Outstanding
367.12102.83222.318.610.463.5217.0816.143.523.61
Inventory
000589.81K676.77K46.28K47.91K46.35K27.39K234.55K
Days Inventory Outstanding
---277.48830.7925.3635.3630.0214.1644.77
Other Current Assets
00269.19K0000000
Total Non-Current Assets
1.33M860.28K798.62K1.53M812.41K763.22K559.34K463.32K299.77K254.85K
Property, Plant & Equipment
000692.45K453.52K223.28K521.49K435.01K267.62K211.82K
Fixed Asset Turnover
---4.99x2.24x8.31x2.74x3.04x5.70x5.43x
Goodwill
0000000000
Intangible Assets
0005.83K3.66K24.04K17.46K13.08K9.47K8.29K
Long-Term Investments
1.33M860.28K798.62K578.53K90.5K16.69K20.17K15.24K22.68K97.49K
Other Non-Current Assets
000249.53K264.74K499.2K0000
Total Assets
5.13M▲ 0%
4.65M▼ 9.3%
4.34M▼ 6.8%
7.21M▲ 66.3%
4.72M▼ 34.5%
2.79M▼ 40.9%
5.74M▲ 105.8%
3.24M▼ 43.6%
24.59M▲ 659.0%
24.91M▲ 0%
Asset Turnover
0.09x0.33x0.20x0.48x0.22x0.67x0.25x0.41x0.06x0.06x
Asset Growth %
121.75%-9.3%-6.8%66.32%-34.48%-40.91%105.77%-43.6%658.99%1652.38%
Total Current Liabilities
144.29K71.4K83.99K1.04M1.31M1.23M1.07M1.12M2.05M2.74M
Accounts Payable
002.79K013.71K28.83K90.43K102.8K90.25K145.22K
Days Payables Outstanding
--1.33-16.8415.866.7566.5746.6553.66
Short-Term Debt
003.95K00000078.32K
Deferred Revenue (Current)
000236.13K279.69K363.02K101.58K96.98K168.6K363.41K
Other Current Liabilities
7.19K077.25K00-384.38K0002.46M
Current Ratio
18.77x53.10x42.11x5.47x2.98x1.65x4.84x2.48x11.82x9.01x
Quick Ratio
18.77x53.10x42.11x4.91x2.46x1.61x4.79x2.44x11.81x8.93x
Cash Conversion Cycle
----814.4113.08-14.3-20.41-28.97-5.28
Total Non-Current Liabilities
000247.23K99.06K0292.09K190.78K110.66K102.08K
Long-Term Debt
0000000000
Capital Lease Obligations
000241.49K83.48K0292.09K190.78K110.66K435.22K
Deferred Tax Liabilities
0005.74K15.57K00000
Other Non-Current Liabilities
0000000000
Total Liabilities
144.29K71.4K83.99K1.29M1.41M1.23M1.36M1.31M2.17M2.84M
Total Debt
003.95K395.76K240.58K82.71K437.72K362.78K229.79K180.4K
Net Debt
-1.86M-2.86M-234.99K-3.12M-381.92K-1.36M-4.39M-1.68M89.71K-38.51K
Debt / Equity
--0.00x0.07x0.07x0.05x0.10x0.19x0.01x0.01x
Debt / EBITDA
---74.14x------0.06x
Net Debt / EBITDA
----584.83x-----0.01x
Interest Coverage
----------
Total Equity
2.56M▲ 0%
4.58M▲ 78.6%
4.25M▼ 7.2%
5.92M▲ 39.4%
3.31M▼ 44.1%
1.56M▼ 52.8%
4.38M▲ 180.4%
1.93M▼ 56.0%
22.43M▲ 1062.5%
22.07M▲ 0%
Equity Growth %
11.26%78.63%-7.18%39.37%-44.09%-52.83%180.38%-55.96%1062.5%2399.87%
Book Value per Share
0.340.610.560.790.440.892.891.5227.9922.06
Total Shareholders' Equity
2.56M4.58M4.25M5.92M3.31M1.54M4.37M1.93M22.46M22.12M
Common Stock
37.18K37.63K37.63K37.65K29.05K7.54K7.71K399100100
Retained Earnings
-279.04K-750.28K-1.09M-734.44K-3.26M-4.95M-7.05M-9.52M-11.8M-12.13M
Treasury Stock
000000-14000
Accumulated OCI
3.74K-799.79K181.02K93.4K9.27K30.21K27.85K-14.69K-28.13K
Minority Interest
0000-33620.51K11.78K-3.79K-33.45K-46.74K

ATPC Cash Flow Statement

Agape ATP Corporation (ATPC) cash flow — operating, investing & free cash flow history

MetricJun'18Jun'19Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-347.98K-667.06K-113.94K-557.95K-845.84K-811.68K-2M-2.73M-2.41M-1.35M
Operating CF Margin %
-71.45%-43.15%-13.27%-16.16%-83.17%-43.72%-139.88%-206.1%-158.33%-
Operating CF Growth %
-247.07%-91.7%82.92%-389.67%-51.6%4.04%-146.63%-36.19%11.47%160.28%
Net Income
-130.27K-519.64K-677.86K354.77K-2.52M-1.67M-2.11M-2.49M-2.31M-1.91M
Depreciation & Amortization
000163.47K217.21K217.94K223.19K226.65K24.9K179.69K
Stock-Based Compensation
0000000000
Deferred Taxes
000178.33K10.13K-14.75K-22022000
Other Non-Cash Items
30.16K474.55K525.23K-510.2K644.05K78.83K24.71K110.69K-92.28K-581.92K
Working Capital Changes
-247.86K-621.97K156.59K-744.32K807.46K572.38K-139.57K-577.74K-38.44K983.5K
Change in Receivables
0-511.61K-85.6K-167.57K167.57K21K-45.67K-21.51K34.78K38.34K
Change in Inventory
00078.67K192.71K343.48K-3.22K-4.22K3.35K1.2K
Change in Payables
035.15K-32.31K-2.8K041.42K38.46K39.55K-7.96K30.9K
Cash from Investing
-1.36M-2.5K-1.5K1.28M-3.96K-32.12K-17.25K-50.05K-23M-400
Capital Expenditures
000-4.73K-3.96K-9.43K-52.32K-50.16K-1.05K-400
CapEx % of Revenue
---0.14%0.39%0.51%3.66%3.79%0.07%0.03%
Acquisitions
-862.49K001.21M000000
Investments
----------
Other Investing
-1.36M0-1.5K-1780-22.69K35.07K112-5000
Cash from Financing
2.93M-5.32K-4.57K-22.09K-19.06K-234.47K5.4M-11.86K23.5M1M
Debt Issued (Net)
2.93M00000-9.59K-11.86K-22.68K-23.69K
Equity Issued (Net)
2.93M000005.41M023M0
Dividends Paid
0000000000
Share Repurchases
000000-93.89K000
Other Financing
-2.92M-5.32K-4.57K-22.09K-19.06K-234.47K00521.33K1.02M
Net Change in Cash
1.22M▲ 0%
-673.67K▼ 155.3%
-3.29M▼ 388.7%
773.14K▲ 123.5%
-919.75K▼ 219.0%
-1.16M▼ 26.1%
3.39M▲ 392.7%
-2.79M▼ 182.3%
-1.9M▲ 31.9%
-358.01K▲ 0%
Free Cash Flow
-347.98K▲ 0%
-667.06K▼ 91.7%
-113.94K▲ 82.9%
-562.86K▼ 394.0%
-849.8K▼ 51.0%
-843.8K▲ 0.7%
-2.05M▼ 143.4%
-2.78M▼ 35.2%
-2.41M▲ 13.0%
-1.35M▲ 0%
FCF Margin %
-71.45%-43.15%-13.27%-16.3%-83.56%-45.45%-143.54%-209.89%-158.4%-89.78%
FCF Growth %
-247.07%-91.7%82.92%-393.98%-50.98%0.71%-143.44%-35.16%13.04%54.65%
FCF per Share
-0.05-0.09-0.02-0.07-0.11-0.48-1.35-2.19-3.01-1.35
FCF Conversion (FCF/Net Income)
2.67x1.28x0.17x-1.57x0.34x0.48x0.95x1.10x1.06x0.71x
Interest Paid
0000000000
Taxes Paid
000288.93K326.84K78.51K34.84K24K06.38K

ATPC Key Ratios

Agape ATP Corporation (ATPC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
-5.35%-14.55%-15.35%6.97%-54.65%-69.2%-70.73%-78.3%-18.72%-8.42%
Return on Invested Capital (ROIC)
-78.85%-31.78%-13.92%-3.48%-48.62%-73.3%-1669.61%-1623.38%-21.46%-10.6%
Gross Margin
9.36%7.07%10.69%77.53%70.76%64.13%65.44%57.39%53.67%54.33%
Net Margin
-26.75%-33.61%-78.94%10.28%-248.21%-90.86%-146.88%-186.77%-149.57%-126.48%
Debt / Equity
--0.00x0.07x0.07x0.05x0.10x0.19x0.01x0.01x
FCF Conversion
2.67x1.28x0.17x-1.57x0.34x0.48x0.95x1.10x1.06x0.71x
Revenue Growth
-217.46%-44.46%302.06%-70.55%82.56%-22.92%-7.57%15.23%16.68%
Related:ATPC Dividend History·ATPC Revenue History·ATPC Price History·ATPC P/E History·ATPC Financial Ratios·ATPC Institutional Holders

ATPC SEC Filings & Documents

Agape ATP Corporation (ATPC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Mar 12, 2026·SEC

Material company update

Mar 10, 2026·SEC

Material company update

Feb 6, 2026·SEC

10-K Annual Reports

3
FY 2026

Apr 13, 2026·SEC

FY 2025

Mar 31, 2025·SEC

FY 2024

Apr 1, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 15, 2026·SEC

FY 2025

Nov 13, 2025·SEC

FY 2025

Aug 13, 2025·SEC

ATPC Frequently Asked Questions

Agape ATP Corporation (ATPC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Agape ATP Corporation (ATPC) reported $1.5M in revenue for fiscal year 2025.

Agape ATP Corporation (ATPC) grew revenue by 15.2% over the past year. This is strong growth.

Agape ATP Corporation (ATPC) reported a net loss of $1.9M for fiscal year 2025.

Dividend & Returns

Agape ATP Corporation (ATPC) has a return on equity (ROE) of -18.7%. Negative ROE indicates the company is unprofitable.

Agape ATP Corporation (ATPC) had negative free cash flow of $1.4M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in ATPC back in 2015?

Total return calculator · dividends reinvested · 11+ years of data

See returns →

How much would $100/month in ATPC be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →